Item 5.07 Submission of Matters to a Vote of Security Holders.
On November 14, 2024, Envoy Medical, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting").
At the Annual Meeting:
|
1.
|
The Company's stockholders (the "Stockholders") elected two Class I director nominees to the Company's Board of Directors to hold office until the earlier of the 2027 annual meeting of stockholders, the election of such director's successor, or such director's death, resignation or removal;
|
|
2.
|
Stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024;
|
|
3.
|
Stockholders approved, on a non-binding and advisory basis, the compensation of the Company's named executive officers; and
|
|
4.
|
Stockholders recommended, on a non-binding and advisory basis, a one-year frequency of votes on named executive officer compensation.
|
The voting results for each such matter were as follows:
|
1.
|
Election of directors:
|
|
Nominee:
|
|
For:
|
|
Withheld:
|
|
Broker Non-Votes:
|
|
Michael Crowe
|
|
11,146,464
|
|
20,254
|
|
2,030,681
|
|
Mona Patel
|
|
11,047,146
|
|
119,572
|
|
2,030,681
|
|
2.
|
Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024:
|
|
For:
|
|
Against:
|
|
Abstain:
|
|
13,173,556
|
|
12,662
|
|
11,181
|
|
3.
|
Approval, on a non-binding and advisory basis, of the Company's named executive officer compensation:
|
|
For:
|
|
Against:
|
|
Abstain:
|
|
Broker Non-Votes:
|
|
11,117,644
|
|
29,673
|
|
19,401
|
|
2,030,681
|
|
4.
|
Recommendation, on a non-binding and advisory basis, of a one-year frequency of votes on named executive officer compensation.
|
|
1 year
|
|
2 years
|
|
3 years
|
|
Abstain
|
|
Broker Non-Votes:
|
|
11,135,620
|
|
11,789
|
|
3,139
|
|
16,170
|
|
2,030,681
|
In light of stockholder approval at the Annual Meeting to hold an advisory vote on the compensation of the Company's named executive officers every year, the Company's Board of Directors has determined to hold an advisory vote on the compensation of the Company's named executive officers every year, until the next advisory vote on the frequency of future advisory votes on the compensation of the Company's named executive officers or until the Board of Directors otherwise determines that a different frequency for such advisory vote would be in the best interests of the Company's stockholders.
